Skip to main content
. 2022 Jul 28;14(8):1572. doi: 10.3390/pharmaceutics14081572

Table 1.

Physicochemical properties of the LNPs examined in screening A.

Entry %CL %DOPE %PEG NaCl Conc.
(mM)
CL PEG ζ-Average
(nm)
PdI ζ-Potential
(mV)
%RNA
Encapsulation
A-1 40 40 0.5 0 CL7H6 PEG-DMG 112 0.20 −3.2 90.3
A-2 50 10 0.5 0 CL4H6 PEG-DMG 121 0.19 −2.3 99.2
A-3 60 10 1 0 CL7H6 PEG-DSG 104 0.15 −2.3 91.0
A-4 60 40 1.5 0 CL7H6 PEG-DMG 128 0.41 −0.6 89.8
A-5 40 25 1.5 0 CL4H6 PEG-DSG 88 0.30 −1.5 99.2
A-6 60 40 0.5 200 CL4H6 PEG-DSG 155 0.13 1.9 98.8
A-7 50 25 1 200 CL4H6 PEG-DMG 138 0.12 −1.1 99.0
A-8 40 10 1.5 200 CL7H6 PEG-DMG 128 0.20 −2.6 85.0
A-9 50 25 1 200 CL7H6 PEG-DSG 171 0.15 −2.7 88.0
A-10 40 40 1 400 CL4H6 PEG-DMG 216 0.08 2.5 99.0
A-11 60 10 1.5 400 CL4H6 PEG-DSG 547 0.19 −1.4 89.2
A-12 50 40 1.5 400 CL7H6 PEG-DSG 108 0.07 −1.7 88.3
A-13 60 25 0.5 400 CL7H6 PEG-DMG 501 0.12 −1.2 91.2
A-14 40 10 0.5 400 CL4H6 PEG-DSG 754 0.17 −10.3 72.4